Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality

COVID-19 convalescent plasma, particularly plasma with high-titer SARS-CoV-2 (CoV2) antibodies, has been successfully used for treatment of COVID-19. The functionality of convalescent plasma varies greatly, but the association of antibody epitope specificities with plasma functionality remains uncha...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgenlander, William, Henson, Stephanie, Monaco, Daniel, Chen, Athena, Littlefield, Kirsten, Bloch, Evan M., Fujimura, Eric, Ruczinski, Ingo, Crowley, Andrew R., Natarajan, Harini, Butler, Savannah E., Weiner, Joshua A., Li, Mamie Z., Bonny, Tania S., Benner, Sarah E., Ashwin Balagopal, Sullivan, David, Shoham, Shmuel, Quinn, Thomas C., Eshleman, Susan, Casadevall, Arturo, Redd, Andrew D., Laeyendecker, Oliver, Ackerman, Margaret E., Pekosz, Andrew, Elledge, Stephen J., Robinson, Matthew, Tobian, Aaron A.R., Larman, H. Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755150/
https://www.ncbi.nlm.nih.gov/pubmed/33354688
http://dx.doi.org/10.1101/2020.12.16.20248294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755150/
https://www.ncbi.nlm.nih.gov/pubmed/33354688
http://dx.doi.org/10.1101/2020.12.16.20248294

Ejemplares similares